Verizon (VZ) EVP Kyle Malady nets shares from performance award, with tax withholding
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Verizon Communications executive Kyle Malady reported equity award activity involving Verizon common stock. On February 11, 2026, he acquired 119,409 shares of common stock at no cost through the vesting of Performance Stock Units that were tied to performance criteria other than Verizon's stock price. On the same date, 58,030 shares were disposed of at $48.97 per share to satisfy tax withholding obligations. After these transactions, Malady directly owned 61,387 shares of Verizon common stock, and indirectly held 19,608 shares through a 401(k) plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
Malady Kyle
Role
EVP and Group CEO-VZ Business
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 119,409 | $0.00 | -- |
| Tax Withholding | Common Stock | 58,030 | $48.97 | $2.84M |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 119,417 shares (Direct);
Common Stock — 19,608 shares (Indirect, By 401(k))
Footnotes (1)
- [object Object]
FAQ
What insider transactions did Verizon (VZ) executive Kyle Malady report?
Kyle Malady reported an equity award vesting and related tax withholding. He acquired 119,409 Verizon common shares through Performance Stock Units and disposed of 58,030 shares at $48.97 per share to cover tax obligations, all dated February 11, 2026.
What executive role does Kyle Malady hold at Verizon (VZ)?
Kyle Malady is reported as an officer of Verizon with the title "EVP and Group CEO-VZ Business." This senior leadership position is disclosed in the Form 4, which also confirms he is not a director or 10% beneficial owner of the company.
How were Kyle Malady’s Performance Stock Units at Verizon (VZ) structured?
The vested Performance Stock Units converted into Verizon common stock based on performance criteria. The filing explains the units were subject to performance measures other than Verizon’s stock price, and upon vesting, 119,409 common shares were issued to Kyle Malady.